Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ACTAVIS INC
2016DJTEVA PHARMACEUTICAL : to Buy Generics Distributor Anda From Allergan for $500 Mi..
2016DJPFIZER : Hit As Sales Of Older Drugs Fall -- WSJ
2016DJBiogen Draws Takeover Interest from Rival Drugmakers--2nd Update
2016DJBiogen Draws Takeover Interest from Rival Drugmakers--2nd Update
2016DJBiogen Draws Takeover Interest from Rival Drugmakers--Update
2016DJBiogen Draws Takeover Interest from Rival Drugmakers
2016DJPfizer Results Beat Expectations
2016DJPFIZER : Profit Surprises as New Product Sales Rise
2016DJFacebook Rides Mobile-Ad Surge -- WSJ
2016 Teva, Allergan win U.S. antitrust approval for generics deal
2016DJTEVA PHARMACEUTICAL : Correction to Teva, Allergan Article
2016DJTEVA PHARMACEUTICAL : Allergan Get FTC Approval for Generics Purchase
2016DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
2016DJJOHNSON & JOHNSON : Jury Acquits Former Johnson & Johnson Unit Executives of Fel..
2016DJJOHNSON & JOHNSON : Jury Acquits Former Johnson & Johnson Unit Executives of Fel..
2016 SoftBank bid for ARM catches some hedge funds off guard
2016DJTEVA PHARMACEUTICAL : Sells $15 Billion of Bonds
2016DJTEVA PHARMACEUTICAL : Finalizes Bond Sale -- Update
2016DJTEVA PHARMACEUTICAL : Finalizes Bond Sale
2016DJTeva Sells $15 Billion of Bonds
2016DJTEVA PHARMACEUTICAL : Allergan Tweak Acquisition Agreement
2016DJTEVA PHARMACEUTICAL : Allergan Tweak Acquisition Agreement
2016DJTeva Raises Guidance
2016DJTEVA PHARMACEUTICAL : Raises Guidance
2016 Shire on a roll as U.S. approves keenly awaited eye drug
2016 EXCLUSIVE - WELLCARE, CENTENE MAKE O : sources
2016DJMayne Pharma Buys US Drugs from Teva, Allergan for $652 Million
2016DJTeva and Allergan Sell Generic Drugs to Impax In Latest Divestiture
2016DJTeva and Allergan Sell Generic Drugs to Impax In Latest Divestiture
2016DJALLERGAN : Former Warner Chilcott Executive Acquitted of Kickbacks Charge
2016DJTeva, Looking to Close Actavis Deal, Sells $40 Million Portfolio to Sagent
2016DJLILLY : German Supreme Court Grants Appeal in Dispute With Actavis
2016DJALLERGAN : Icahn Takes Big Stake in Allergan, Endorses Drugmaker's CEO
2016 Anacor received rival bid before Pfizer deal - filing
2016DJPfizer Buys Anacor In Turn to Smaller Deals -- WSJ
2016DJPfizer to Buy Anacor for $4.5 Billion--2nd Update
2016DJPfizer to Buy Anacor for $4.5 Billion--Update
2016DJPfizer to Buy Anacor for $4.5 Billion
2016DJPfizer to Buy Anacor for $4.5 Billion
2016 Baupost took $461 million Allergan stake before Pfizer deal collapsed
2016DJMarkit's Profit Falls on Higher Personnel Costs
2016DJALLERGAN : Uterine Fibroids Treatment Shows Efficacy
2016DJTEVA PHARMACEUTICAL : Revenue Declines as Some Drugs Lose Exclusivity
2016DJEndo Cuts Annual Guidance on Impairment Charge
2016DJPFIZER : Reports Rock-Solid Quarter, Sees Stronger Year Ahead
2016DJPfizer Guides Higher, Mulls Breakup of Company
2016DJNew Tax Inversion Rules Complicate Equipment-Maker Deal
2016DJJOSEPH PAPA : Valeant Names Joseph Papa as New CEO
2016DJAllergan Completes Licensing Deal After Pfizer Bid Collapses
2016DJAllergan Completes Licensing Deal After Pfizer Bid Collapses
2016 Mega deals morph into mega problems for Wall Street
2016DJPfizer, Allergan to Hunt for Deals of Their Own
2016 Oil, healthcare boost stocks; dollar weak after minutes
2016 Oil, healthcare boost global stocks; dollar weak after minutes
2016DJPFIZER : Treasury Has Outsize Legal Leverage on Inversions
2016DJFDA Approves Medtronic Pacemaker That Attaches Directly to Heart
2016 Mega-deal collapse a second-quarter wake-up for merger-arb hedge funds
2016DJAllergan CEO Saunders Criticizes Treasury Rules That Scuttled Pfizer Deal
2016DJPFIZER : Allergan End Merger Agreement -- 2nd Update
2016 Democratic White House hopefuls cheer end of Pfizer, Allergan deal
2016 Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change
2016 Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change
2016DJMedtronic Says New Inversion Rules Won't Hurt Finances
2016DJPFIZER : Files 8K - Termination Of Definitive Agreement
2016DJPfizer, Allergan End Merger Agreement -- Update
2016DJPfizer Walks Away From Allergan Deal
2016DJPFIZER : Drops Allergan Takeover -- WSJ
2016DJHealth-Care Companies Lead U.S. Stocks Higher
2016 Obama's inversion curbs kill Pfizer's $160 billion Allergan deal
2016DJPFIZER : to Walk Away From Allergan Deal
2016DJPFIZER : to Walk Away From Allergan Deal
2016 Dollar touches 17-month low vs yen as stocks slump
2016 Obama urges Congress to take action on corporate tax reform
2016 Dollar drops to 17-month low vs. yen as stocks slump
2016 EXCLUSIVE : Pfizer leaning towards abandoning deal with Allergan - source
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2017 15 821 M
EBIT 2017 7 624 M
Net income 2017 -1 759 M
Debt 2017 17 074 M
Yield 2017 1,31%
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 5,74x
EV / Sales 2018 5,33x
Capitalization 73 730 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 273 $
Spread / Average Target 24%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
Paul M. Bisaro Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ACTAVIS INC73 730
JOHNSON & JOHNSON10.23%342 817
ROCHE HOLDING LTD.14.79%237 610
NOVARTIS AG6.28%213 719
PFIZER INC.-1.11%191 279
MERCK & CO., INC.8.78%175 160
More Results